KRAS and cancer: Genetic [6, 7] and tissue-related factors, as well as nutrients and cytokines in the stromal environment of the tumor, affect cancer metabolic rewiring (CMR) [8, 9], i.e., CMR may be activated by oncogenic K-Ras, which is mutated in approximately 35% of lung adenocarcinomas and 45% of colorectal cancers.